BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zampino R, Pisaturo MA, Cirillo G, Marrone A, Macera M, Rinaldi L, Stanzione M, Durante-Mangoni E, Gentile I, Sagnelli E, Signoriello G, Miraglia Del Giudice E, Adinolfi LE, Coppola N. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration. Ann Hepatol. 2015;14:75-82. [PMID: 25536644 DOI: 10.1016/s1665-2681(19)30803-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Zhao K, Su X, Gao X, Yao Y, Kong R, Wang Y, Wu C, Lu M, Chen X, Pei R. Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection. Virol Sin 2022:S1995-820X(22)00065-7. [PMID: 35523417 DOI: 10.1016/j.virs.2022.04.001] [Reference Citation Analysis]
2 Messina V, Pisaturo M, Alessio L, Russo A, Tripaldelli E, Petruzziello A, Annechiaro A, Romano MR, Maggi P, Coppola N. HEPATITIS C VIRUS (HCV) MICRO-ELIMINATION IN THE HOSPITAL SETTING: THE RESULTS OF THE HCV CASERTA HOSPITAL PROJECT. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.04.003] [Reference Citation Analysis]
3 Zhang J, Huang Z, Liu X, Wu C, Zhou W, Ye P, Stalin A, Lu S, Tan Y, Wu Z, Fan X, Zhang X, Wang M, Li B, Cheng G, Mou Y, Wu J, Wan S. Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/6213865] [Reference Citation Analysis]
4 D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 48] [Article Influence: 28.0] [Reference Citation Analysis]